newsfilter.io

Yassaman Salas

Showing 11 of 1 transcripts.

  1. Goldman Sachs31 min

    Reimagining Biopharma: Precision Medicine, Patients, and Purpose with Takeda CEO-Elect

    Julie Kim, Yassaman Salas

    Takeda's Board unanimously appointed Julie Kim as the incoming President and CEO, effective June 2026, to steer the $30 billion pharmaceutical giant through a strategic overhaul centered on AI-driven discovery and organic growth. During her incoming tenure, Kim plans to leverage the company's Japanese headquarters for geopolitical flexibility while navigating complex regulatory hurdles regarding Chinese clinical data and U.S. pricing structures. Her leadership strategy emphasizes "market innovation" to improve patient access and utilizes a "giving people an A" philosophy to accelerate talent development within the organization.